14 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
will present data from the Phase 1/2 trial for XTX202 in advanced solid tumors in a poster presentation at the 2024 American Society of Clinical Oncology
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
7 Dec 23
Other Events
7:45am
and immuno-oncology (IO) refractory solid tumors. The data were presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
8-K
XLO
Xilio Therapeutics Inc
7 Dec 23
Other Events
7:45am
XTX101 in patients with advanced solid tumors. These data were presented at the European Society for Medical Oncology Immuno-Oncology Congress on December
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
, Xilio announced initial Phase 1/2 monotherapy safety, PK, pharmacodynamic (PD) and anti-tumor activity data for XTX202 at the Society for Immunotherapy … data and outlining the planned Phase 2 trial design at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress on December 6
8-K
EX-99.1
rtygviv 5dzp
3 Nov 23
Other Events
4:05pm
8-K
EX-99.2
ijqoq003
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
zj2brmc2zkwbcq
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
o7n1mfyh 7p
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
9qemv xml
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
8-K
EX-99.2
44vp1q
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
0vbq42dzzcze 6rszi
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
gnmz fn3tte
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
8-K
EX-99.1
o1v7lgzz1p2ec f87
2 Dec 21
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
8:00am
- Prev
- 1
- Next